Losartan prevents the mesangial cell‐myofibroblast transdifferentiation induced by high glucose and angiotensin II

Authors :: Carine Prisco Arnoni
Luciana G. Pereira
Edgar Maquigussa
Mirian A. Boim
Source :: The FASEB Journal. 24
Publication Year :: 2010
Publisher :: Wiley, 2010.

Subjects :: medicine.medical_specialty
Mesangial cell
Chemistry
Transdifferentiation
Biochemistry
Angiotensin II
Endocrinology
Losartan
Internal medicine
High glucose
Genetics
medicine
Molecular Biology
Myofibroblast
Biotechnology
medicine.drug

Full Text Access

Tools